Shiyan Zhang

Shiyan Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in Acta Crystallographica Section F Structural Biology Communications
Verified
Journal Article
Closed access
PDF file
NCNuo Cheng
Nuo Cheng
HZHao Zhang
Hao Zhang
SZShiyan Zhang
Shiyan Zhang
XMXiaodan Ma
Xiaodan Ma
GMGuoyu Meng
Guoyu Meng

7 March 2026 in iScience
Verified
Journal Article
Open access
HLHao Lu
Hao Lu
FZFengyi Zeng
Fengyi Zeng
JSJiao Sun
Jiao Sun
BLBaiyang Li
Baiyang Li
ZLZhimei Lei
Zhimei Lei
SZShiyan Zhang
Shiyan Zhang
Parkinson disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons and the pathological accumulation of α-synuclein (α-syn), a key neuronal protein implicated in neuroinflammation and disease progression. The NOD-like receptor protein 3 (NLRP3) inflammasome, a critical component of the innate immune system, serves as a macromolecular sensor for damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs). Its aberrant activation drives chronic neuroinflammation, which exacerbates PD pathology. This review elucidates the molecular mechanisms underlying NLRP3 inflammasome activation and its intricate relationship with PD, emphasizing the role of α-syn as a DAMP that triggers NLRP3 via Toll-like receptors (TLRs) and mitochondrial dysfunction. The review highlights how mitochondrial impairment and lysosomal disruption amplify NLRP3 activation, creating a vicious cycle of neuroinflammation and neuronal death. Importantly, emerging evidence demonstrates that plant natural products (PNPs) can effectively target the NLRP3 inflammasome pathway, offering a promising avenue for PD therapy. This review not only establishes the NLRP3 inflammasome as a pivotal macromolecular target in PD therapy but also systematically demonstrates, from the perspectives of structural biology, immunology, and translational medicine, the significant value of PNPs as a novel class of precision neuroprotective modulators—thereby laying a theoretical foundation for developing multi-target, low-toxicity therapeutic agents against PD.